Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., announced that part of the bank account funds of its subsidiary, Kasma Holdings Ltd., have been frozen due to a contractual dispute with Tianjin Rongda Weiye Technology Development Co., Ltd. [3][4] - The total amount frozen is 9,002,802.54 yuan, which represents 0.84% of the company's audited net assets as of December 31, 2024, and 0.87% of the net assets as of June 30, 2025. It also accounts for 1.93% of the company's audited cash and cash equivalents as of December 31, 2024, and 2.86% as of June 30, 2025. [2][4] - The company stated that the frozen funds constitute a small proportion of its cash resources and will not have a significant adverse impact on its production and operational activities. [2][4] Group 2 - The company is taking effective legal measures to resolve the dispute and aims to address the issue of the frozen account funds promptly, ensuring the protection of the company's and investors' legal rights. [5] - The company emphasizes that all information should be verified through its designated disclosure media, including Shanghai Securities News and Securities Times, as well as the Shanghai Stock Exchange website. [5]
上海阿拉丁生化科技股份有限公司关于公司的控股子公司部分银行账户资金被冻结的公告